From Content To Catalyst: Operationalizing Behavioral Science In Medical Affairs
This webinar introduces a structured Behavioral Insight Engine — a practical framework for embedding behavioral science across Medical Affairs strategy and execution.
This webinar introduces a structured Behavioral Insight Engine — a practical framework for embedding behavioral science across Medical Affairs strategy and execution.
The Medical, Legal, and Regulatory (MLR) review process is critical for ensuring compliance and accuracy in pharmaceutical and healthcare communications—but it’s often time-consuming and resource-intensive.
In this session, two Medical Affairs leaders will share case studies illustrating how they built global organizations with lean U.S. teams—offering practical insights for achieving efficiency, maintaining quality, and driving meaningful global impact.
In this session, two Medical Affairs leaders will share case studies illustrating how they built global organizations with lean U.S. teams—offering practical insights for achieving efficiency, maintaining quality, and driving meaningful global impact.
Whether you’re considering broadening your current engagement strategy or looking to understand the evolving Medical Affairs landscape, this session will provide valuable insights and practical guidance for multi-stakeholder engagement.
Whether you’re considering broadening your current engagement strategy or looking to understand the evolving Medical Affairs landscape, this session will provide valuable insights and practical guidance for multi-stakeholder engagement.
This session will explore Part 2 of our 3-part MAPS series turns insight into action. In Part 1, we unpacked Daniel Goleman’s five elements of Emotional Intelligence (EI). Now we put EI to work.
Discover how top-down patient engagement transforms Medical Affairs—driving true patient-centricity, meaningful impact, and lasting success.
Explore how AI-driven real-world data reveals trends in Alzheimer’s screening, testing, and treatment—and highlights where inequities persist.
Explore how AI-driven real-world data reveals trends in Alzheimer’s screening, testing, and treatment—and highlights where inequities persist.
